ES2075993T3 - Procedimiento para la determinacion de la presencia o ausencia de infecciones por el virus de epstein-barr. - Google Patents

Procedimiento para la determinacion de la presencia o ausencia de infecciones por el virus de epstein-barr.

Info

Publication number
ES2075993T3
ES2075993T3 ES92117392T ES92117392T ES2075993T3 ES 2075993 T3 ES2075993 T3 ES 2075993T3 ES 92117392 T ES92117392 T ES 92117392T ES 92117392 T ES92117392 T ES 92117392T ES 2075993 T3 ES2075993 T3 ES 2075993T3
Authority
ES
Spain
Prior art keywords
absence
epstein
infections
determination
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117392T
Other languages
English (en)
Inventor
Marinko Dobec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST VIRION AG
Original Assignee
INST VIRION AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST VIRION AG filed Critical INST VIRION AG
Application granted granted Critical
Publication of ES2075993T3 publication Critical patent/ES2075993T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA EL CONOCIMIENTO DE LA PRESENCIA O DE LA AUSENCIA DE ANTICUERPOS CONTRA EL ANTIGENO DE LA ENVOLTURA Y CONTRA EL ANTIGENO DEL NUCLEO DEL VIRUS EPSTEIN-BARR EN UN LIQUIDO BIOLOGICO, POR MEDIO DE MEDICION DE LA FLUORESCENCIA Y VALORACION MICROSCOPICA DE LA FLUORESCENCIA, QUE ESTA CARACTERIZADO PORQUE SE EMPLEA LA TECNICA INMUNOFLUORESCENCIAANTICOMPLEMENTO Y COMO ANTIGENO CELULAS P3HR-1.
ES92117392T 1991-10-25 1992-10-12 Procedimiento para la determinacion de la presencia o ausencia de infecciones por el virus de epstein-barr. Expired - Lifetime ES2075993T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH312891 1991-10-25

Publications (1)

Publication Number Publication Date
ES2075993T3 true ES2075993T3 (es) 1995-10-16

Family

ID=4249221

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117392T Expired - Lifetime ES2075993T3 (es) 1991-10-25 1992-10-12 Procedimiento para la determinacion de la presencia o ausencia de infecciones por el virus de epstein-barr.

Country Status (5)

Country Link
EP (1) EP0538703B1 (es)
JP (1) JPH05215753A (es)
CA (1) CA2081131A1 (es)
DE (1) DE59202707D1 (es)
ES (1) ES2075993T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4438833A1 (de) * 1994-10-31 1996-05-02 Bayer Ag Verfahren zur analytischen Trennung von Viren
EP0834742A1 (de) * 1996-10-01 1998-04-08 Gull Laboratories GmbH Spezifischer Anti-EBNA-1-Test mittels antikomplementärer Immunfluoreszenz
ATE342029T1 (de) 1997-04-08 2006-11-15 Kimberly Clark Co Wegwerfbekleidung und ihre herstellung
CN102207500A (zh) * 2011-03-11 2011-10-05 中国兽医药品监察所 补体结合酶联免疫吸附试验

Also Published As

Publication number Publication date
DE59202707D1 (de) 1995-08-03
JPH05215753A (ja) 1993-08-24
EP0538703B1 (de) 1995-06-28
EP0538703A1 (de) 1993-04-28
CA2081131A1 (en) 1993-04-26

Similar Documents

Publication Publication Date Title
CY1107652T1 (el) Μεθοδος ποσοτικης ανιχνευσης ζωντων επιθηλιακων κυτταρων ογκου σε ενα βιολογικο υγρο
ES2052610T3 (es) Un metodo de determinacion de anfetamina y/o metanfetamina en una muestra de ensayo.
AR026735A1 (es) Inmunoensayo para insecticidas de neonicotinilo
BRPI0011562B8 (pt) aparelho e método para tratamento de um fluido biológico.
AR001811A1 (es) Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones
BG104951A (en) Method for marking liquids with at least two marker substances and method for detecting them
DE60234181D1 (de) Zwei photonen absorbierende bordipyrromethen-difluorid-farbstoffe und ihre anwendungen
Rudnick et al. Photoinactivation of the beta-galactoside transport system in Escherichia coli membrane vesicles with 2-nitro-4-azidophenyl-1-thio-beta-D-galactopyranoside.
WO2003095968A3 (fr) Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectueux
ES2075993T3 (es) Procedimiento para la determinacion de la presencia o ausencia de infecciones por el virus de epstein-barr.
Kongsomros et al. Comparison of viral inactivation methods on the characteristics of extracellular vesicles from SARS‐CoV‐2 infected human lung epithelial cells
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
ES2054113T3 (es) Sistema de inactivacion viral para bolsas de sangre.
MX170741B (es) Composicion de lavado equipo de prueba y su uso para determinar un antigeno viral del herpes simplex
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
CN109425741A (zh) 一种适用于吖啶酯发光体系的化学发光底物液
Bećarević et al. Effect of ultra-violet light on tobacco mosaic virus containing 5-fluorouracil
DE60222091D1 (de) Dendritische chemilumineszierende Substrate
ES2170845T3 (es) Procedimiento para la inactivacion de virus en proteinas.
Montemayor et al. Comparative study between two laser scanning cytometers and epifluorescence microscopy for the detection of Cryptosporidium oocysts in water
Alotaibi et al. Solar disinfection of water for inactivation of enteric viruses and its enhancement by riboflavin
ES2093601T3 (es) Inmunoensayo de polarizacion de fluorescencia para tetrahidrocannabinoides.
Ushimi et al. Study of the one-step growth curve of equine infectious anemia virus by immunofluorescence
WO2001096383A3 (en) High fluorescent intensity cross-linked allophycocyanin
DK439086A (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 538703

Country of ref document: ES